Empowered Funds
ZVRA icon

Empowered Funds’s Zevra Therapeutics ZVRA Stock Holding History

Empowered Funds’s Portfolio ZVRA Stock Details ZVRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$820K Buy
+74,764
New +$886K ﹤0.01% 1623

Other funds holding ZVRA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Nantahala Capital Management
Nantahala Capital Management New Canaan, Connecticut $3.16B AUM 31.44% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.96T AUM 27.49% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $234B AUM 43.58% 1-Year Est. Return
Integrity Alliance
Integrity Alliance Urbandale, Iowa $3.28B AUM 15.79% 1-Year Est. Return

Empowered Funds's ZVRA Position: Q3 2026 in Review

Empowered Funds opened a new position in Zevra Therapeutics (ZVRA) in Q3 2026: 74,764 shares worth $820K. The stake represents ﹤0.01% of the portfolio and ranks #1623 among its holdings.

129 funds tracked by Wall St. Rank hold ZVRA as of Q3 2026.

  • Empowered Funds held 74,764 shares of Zevra Therapeutics worth $820K as of Q3 2026.
  • Zevra Therapeutics was a new Empowered Funds position in Q3 2026.
  • Zevra Therapeutics made up ﹤0.01% of Empowered Funds's portfolio in Q3 2026, its #1623 holding.
  • 129 funds tracked by Wall St. Rank held Zevra Therapeutics as of Q3 2026.

Based on Empowered Funds's 13F filing for Q3 2026, filed 13 Nov 2026.